Côd QR

Low-Dose Oral Minoxidil as Treatment for COVID-19-Related Telogen Effluvium: Results From a Retrospective Series of 69 Patients

Background and objective: Coronavirus disease 2019 (COVID-19) associated telogen effluvium (CATE) has been observed in patients after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although it is self-limiting, hair loss can be very distressing, and some patients may se...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: C.D. Villarreal-Villarreal, E. Boland-Rodriguez, D. Mares-Custodio, D. Asz-Sigall, J.F. Molina-de la Garza, D. Saceda-Corralo, S. Vano-Galvan
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2026-05-01
Cyfres:Actas Dermo-Sifiliográficas
Pynciau:
Androgenetic alopecia
Minoxidil
Hair loss
Hair shedding
COVID-19
Telogen effluvium
Mynediad Ar-lein:http://www.sciencedirect.com/science/article/pii/S0001731025008452
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg